Pacira Pharm Inc
(PCRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,397 | -35 | 4,812 | -99,560 | -115,601 |
| Depreciation Amortization | 72,102 | 50,229 | 22,035 | 82,007 | 59,896 |
| Income taxes - deferred | 10,221 | 2,149 | 1,397 | 20,621 | 17,113 |
| Accounts receivable | -1,943 | -1,046 | 8,559 | -7,748 | 4,903 |
| Accounts payable and accrued liabilities | -2,669 | 9,344 | 2,464 | 3,084 | 3,409 |
| Other Working Capital | -55,380 | -40,010 | -1,451 | -18,519 | 272 |
| Other Operating Activity | 80,577 | 26,840 | -2,357 | 209,504 | 186,265 |
| Operating Cash Flow | $108,305 | $47,471 | $35,459 | $189,389 | $156,257 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -1,250 | -1,250 | N/A | N/A | N/A |
| PPE Investments | -15,115 | -11,245 | -8,548 | -10,636 | -8,518 |
| Net Acquisitions | -16,702 | -16,702 | -16,702 | N/A | N/A |
| Purchase Of Investment | -113,450 | -74,685 | -69,629 | -252,212 | -207,017 |
| Sale Of Investment | 226,665 | 140,416 | 69,250 | 179,572 | 132,627 |
| Investing Cash Flow | $80,148 | $36,534 | $-25,629 | $-83,276 | $-82,908 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 101,000 | 0 | N/A | N/A | N/A |
| Debt Repayment | -312,799 | -6,563 | -2,813 | 76,615 | 79,427 |
| Common Stock Issued | 1,581 | 1,569 | N/A | 2,298 | 1,364 |
| Common Stock Repurchased | -100,080 | -50,039 | N/A | -25,000 | -25,000 |
| Other Financing Activity | -7,677 | -5,466 | -181 | -36,550 | -36,473 |
| Financing Cash Flow | $-317,975 | $-60,499 | $-2,994 | $17,363 | $19,318 |
| Exchange Rate Effect | 337 | 204 | N/A | N/A | N/A |
| Beginning Cash Position | 276,774 | 276,774 | 276,774 | 153,298 | 153,298 |
| End Cash Position | 147,589 | 300,484 | 283,610 | 276,774 | 245,965 |
| Net Cash Flow | $-129,185 | $23,710 | $6,836 | $123,476 | $92,667 |
| Free Cash Flow | |||||
| Operating Cash Flow | 108,305 | 47,471 | 35,459 | 189,389 | 156,257 |
| Capital Expenditure | -15,115 | -11,245 | -8,548 | -10,636 | -8,518 |
| Free Cash Flow | 93,190 | 36,226 | 26,911 | 178,753 | 147,739 |